However, it remains unclear if CVB-D could ameliorate oxidative stress via the activation of Nrf2 signalling pathways and thereby prevent the cardiac pathologic structural damage and function disorder caused by diabetes. The gene discussed is NFE2L2; the disease is diabetes mellitus.